Detalhe da pesquisa
1.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
2.
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study.
Future Oncol
; 19(14): 975-982, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293766
3.
The world apheresis association registry, 2023 update.
Transfus Apher Sci
; 62(6): 103831, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827962
4.
Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation.
J Clin Apher
; 38(6): 685-693, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503703
5.
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.
Br J Haematol
; 193(2): 325-338, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605445
6.
Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis.
Transfus Med Hemother
; 48(4): 234-239, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34539317
7.
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation.
Clin Transplant
; 34(10): e14049, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713042
8.
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia.
Clin Lab
; 66(9)2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32902222
9.
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.
Blood
; 139(4): 624-629, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758066
10.
A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System.
Cells Tissues Organs
; 207(1): 15-20, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31357194
11.
Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft.
Transfus Apher Sci
; 58(2): 192-195, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928229
12.
Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients.
Transfus Apher Sci
; 58(5): 659-662, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31542336
13.
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.
Haematologica
; 103(4): 698-706, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29419437
14.
JACIE: A 20 year-old voluntary body functioning worldwide.
Transfus Apher Sci
; 57(2): 153-158, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801765
15.
Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice.
Transfus Apher Sci
; 57(6): 762-767, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249533
16.
[Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA external quality assessment national program results]. / MOTAKK HBV DNA ve HCV RNA dis kalite kontrol ulusal programi 2015-2016 sonuçlarinin degerlendirilmesi.
Mikrobiyol Bul
; 52(4): 348-366, 2018 Oct.
Artigo
em Turco
| MEDLINE | ID: mdl-30522421
17.
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study.
Haematologica
; 102(11): 1913-1922, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935843
18.
Subsequent malignancies after allogeneic hematopoietic stem cell transplantation.
Clin Transplant
; 31(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432802
19.
The effect of age on peripheral stem cell mobilization in healthy donors, single center experience.
J Clin Apher
; 32(1): 16-20, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958783
20.
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
Lancet Oncol
; 17(10): 1409-1418, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637985